Navigation Links
Colleen’s Dream Foundation Donates $10,000 to Johns Hopkins Medicine for Ovarian Cancer Research
Date:7/24/2014

Phoenix, AZ (PRWEB) July 24, 2014

Colleen’s Dream Foundation, in partnership with Fidelity National Title Agency, has donated $10,000 to Johns Hopkins Medicine to fund ovarian cancer research, according to Colleen’s Dream Foundation President Billy Cundiff.

According to Cundiff, this is the second year in a row Colleen's Dream Foundation has supported ovarian cancer research at Johns Hopkins Medicine.

“One of the main goals of Colleen's Dream Foundation is to work with promising young investigators at some of the top research hospitals and universities that are researching ovarian cancer,” says Cundiff. "So it only makes sense that we are once again supporting ovarian cancer research being conducted at Johns Hopkins.”

Cundiff says this year's grant to Johns Hopkins will go to Dr. Hiroyasu Kashima.

According to Dr. Robert Kurman, Director of the Division of Gynecologic Pathology at Johns Hopkins Medicine, Dr. Kashima’s research currently focuses on the prevention of ovarian cancer.

“Prevention is probably the most effective way of reducing morbidity and mortality from ovarian cancer,” says Kurman. “Dr. Kashima’s research, which focuses on re-purposing a drug that has been used for many years for use in preventing ovarian cancer, would be an important breakthrough.”

Kurman adds the grant from Colleen’s Dream Foundation will both support Dr. Kashima’s research and help to launch him as an independent ovarian cancer investigator.

“In his future work, Dr. Kashima will study the molecular mechanisms underlying how statins prevent the development of ovarian cancer,” says Kurman. “These studies will provide the biological basis for the development of clinical trials to determine whether statins can indeed prevent ovarian cancer in high-risk women.”

Cundiff, who is the kicker for the Cleveland Browns, says the $10,000 grant supporting Dr. Kashima's ovarian cancer research is a direct result of the sponsorship and support provided by Dustin Gaskey and Fidelity National Title Insurance Company in Phoenix, Arizona.

"Dustin and his team at Fidelity National Title have been amazing. Their dedication to Colleen's Dream and our mission is remarkable,” says Cundiff. “We are honored that they have joined us in supporting the valuable ovarian cancer research that Dr. Kashima is performing at Johns Hopkins."

Gaskey says it was an easy decision to partner with Cundiff and Colleen’s Dream Foundation to help fight ovarian cancer.

"As a father, a husband, a brother, and a son…participating with Colleen's Dream Foundation to assist in the early detection of ovarian cancer is a no brainier for us,” says Gaskey. “We thank the entire team for the opportunity to be a member of the Colleen's Dream Family."

ABOUT OVARIAN CANCER:

Ovarian cancer is often referred to as “the silent killer” because many women do not discover their disease until it is in the late stages, which leads to many women succumbing to the disease within a short period of time. Unlike cervical or breast cancer, ovarian cancer does not have a standardized early detection procedure. When it comes to women’s health, ovarian cancer proves to be one of the deadliest diseases.

ABOUT COLLEEN’S DREAM FOUNDATION:

Colleen’s Dream Foundation started in 2012 and supports research for early detection and improved treatment for ovarian cancer. The story of Colleen’s Dream started in 2007 when Colleen Drury – Nicole Cundiff’s mother and Billy Cundiff’s mother-in-law – was diagnosed with late-stage ovarian cancer. The family became aware of a new world that was filled with invasive surgery, harsh chemotherapy, and lots of uncertainty, and realized they needed to help others who were dealing with ovarian cancer.

Colleen’s Dream Foundation believes it is important to raise money for research that will lead to reliable early detection testing and improved treatment for ovarian cancer. Because so little is known about ovarian cancer in proportion to other women’s health issues, there is an incredible opportunity for research and education.

Go here to find out more about Colleen’s Dream Foundation.

Colleen's Dream Foundation is a qualified 501 (c)(3) tax exempt non-profit organization based in Phoenix, Arizona.

Read the full story at http://www.prweb.com/releases/2014/06/prweb11958034.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Colleen’s Dream Foundation Gifts $10,000 to The University of Texas MD Anderson Cancer Center to Support Ovarian Cancer Research
2. Colleen’s Dream Foundation's First ‘Young Investigator’ Grant Directed to Dr. Felix Zeppernick of Johns Hopkins University
3. Colleen’s Dream Foundation Gifts $10,000 to The University of Arizona Cancer Center to Support Early Ovarian Cancer Detection Research
4. Ride AZ Promotions Hosted a Successful 'Colleen’s Dream Ride' with Over 300 Riders Raising Over $8,000 to Support Colleen’s Dream Foundation
5. Renowned Jewelry Designer Kendra Scott Hosted a Successful ‘Kendra Gives Back’ Party Benefitting Colleen’s Dream Foundation in Scottsdale, AZ
6. Colleen’s Dream Foundation Makes Its First Ovarian Cancer Research Grant to John Hopkins University to Celebrate World Ovarian Cancer Day
7. Drake University’s Phi Gamma Delta (FIJI) “Kicking Cancer with NFL Kicker Billy Cundiff” Exceeds Fundraising Expectations Raising Over $8,000 for Colleen’s Dream Foundation
8. A Dream Team in Diabetes Research Made Possible by Fraternal Order Of Eagles (FOE)
9. 5K To Marathon Training Website, Rundreamachieve, Adds The R.D.A. Max International Team To List Of Services
10. DreamsCloud Launches New Interactive iOS App, DreamSphere
11. Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... Denver, CO. (PRWEB) , ... August 22, 2017 , ... Each of the past six ... to take attractive pictures of these labels and stickers, demonstrating the variety and creativity of ... great group of label images came in. Now, it's time to announce the winners of ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky farm and ... Martha McKown, an ordained United Methodist minister with graduate degrees in Religious Education and ... sisters studied High School literature. She loved the early English folk ballads, especially ...
(Date:8/22/2017)... KS (PRWEB) , ... August 22, 2017 , ... TopConsumerReviews.com ... products to fight Fatigue . , As the stress of modern life continually ... up the pace. Constant use of artificial stimulants can trap people in vicious high/low ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... Stevens as a 2017-2018 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon running has surged ... country. , Outdoor running increases exposure to ultraviolet radiation, a carcinogen that promotes ... melanoma, and only half may be adequately protecting themselves with proper clothing and ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... E.I. Medical Imaging (EIMI) has partnered with ... design the worlds first ultrasound system to be used underwater ... habitat. In preparation for a piece produced by Icon ... Dr. Guttridge approached EIMI with the idea of an underwater ... sharks underwater. EIMI ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 The ... treat rare nervous system diseases, has concluded a worldwide license ... the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing ... in a Phase 2 study conducted in Europe ... the United States ...
Breaking Medicine Technology: